SYS-CON MEDIA Authors: Elizabeth White, Pat Romanski, Liz McMillan, Yeshim Deniz, Courtney Abud

News Feed Item

Advanced Medical Optics Announces Its 3 1/2% Convertible Senior Subordinated Notes Due 2023 Are Convertible During the Fourth Quarter of 2005

Advanced Medical Optics Announces Its 3 1/2% Convertible Senior Subordinated Notes Due 2023 Are Convertible During the Fourth Qu

SANTA ANA, Calif., Oct. 14 /PRNewswire-FirstCall/ -- Advanced Medical Optics, Inc. (AMO) , today announced that under the terms of the indenture governing its 3 1/2% Convertible Senior Subordinated Notes Due 2023 (the "Notes"), each holder of Notes may, at such holder's option, convert its Notes into shares of AMO common stock, par value $0.01 per share, during the quarter ending December 31, 2005, at a conversion rate of 48.6914 shares per $1,000 principal amount of Notes. As of September 30, 2005, AMO had approximately $5.6 million in principal amount of Notes outstanding, and shares issuable upon conversion of the Notes have already been included in AMO's calculation of weighted average diluted shares outstanding.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050324/AMOLOGO )

Under the terms of the indenture, each holder has the right to convert such holder's Notes during any fiscal quarter if the closing sale price of AMO's common stock for at least 20 trading days in the 30 consecutive trading-day period ending on the last trading day of the immediately preceding fiscal quarter exceeds 120% of the conversion price in effect at the close of business on each of such 30 consecutive trading days. As of the close of business on September 30, 2005, the sale price of AMO's common stock had exceeded the conversion price of $20.538 per share by 120% for at least 20 trading days during the 30 consecutive trading-day period ending on September 30, 2005. As a result of this event, the Notes are convertible during the fiscal quarter ending on December 31, 2005. Upon conversion, AMO will have the right to deliver shares of common stock, cash or a combination of cash and shares of common stock. AMO will inform a converting holder of its election no later than two business days following such holder's conversion date. AMO will pay cash in lieu of issuing any fractional shares of common stock.

This press release is only a summary of certain provisions of the Notes and the indenture governing the Notes. A complete explanation of the conversion rights of holders of the Notes, as well as the procedures required to convert Notes, is set forth in the indenture. All holders are urged to review the conversion provisions contained in the Notes and the indenture in their entirety.

About Advanced Medical Optics (AMO)

AMO is a global medical device leader focused on the discovery and delivery of innovative vision technologies that optimize the quality of life for people of all ages. Products in the ophthalmic surgical line include intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery. AMO owns or has the rights to such ophthalmic surgical product brands as ReZoom(TM), Phacoflex(R), Clariflex(R), Array(R), Sensar(R), CeeOn(R), Tecnis(R) and Verisyse(TM) intraocular lenses, STAR S4 IR(TM) laser vision correction system, WaveScan Wavefront(R) System, CustomVue(TM) procedure, Sovereign(R) and Sovereign(R) Compact(TM) phacoemulsification systems with WhiteStar(TM) technology, Amadeus(TM) and Amadeus(TM) II microkeratomes, Healon(R) and Vitrax(R) viscoelastics, and the Baerveldt(R) glaucoma shunt. Products in the contact lens care line include disinfecting solutions, daily cleaners, enzymatic cleaners and lens rewetting drops. Among the contact lens care product brands the company possesses are COMPLETE(R) Moisture PLUS(TM), COMPLETE(R) Blink-N-Clean(R), Consept(R)F, Consept(R) 1 Step, Oxysept(R) 1 Step, UltraCare(R), Ultrazyme(R), Total Care(R) and blink(TM) branded products. Amadeus is a licensed product of, and a trademark of, SIS, Ltd. AMO is based in Santa Ana, California, and employs approximately 3,500 worldwide. The company has operations in 24 countries and markets products in approximately 60 countries. For more information, visit the company's Web site at http://www.amo-inc.com/.

Investor Contact: Erika Richmond (714) 247-8348 [email protected]

Advanced Medical Optics

CONTACT: Investors, Erika Richmond of Advanced Medical Optics,
+1-714-247-8348, [email protected]

Web site: http://www.amo-inc.com/

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Eggplant, the customer experience optimization specialist, announced the latest enhancements to its Digital Automation Intelligence (DAI) Suite. The new capabilities augment Eggplant’s continuous intelligent automation by making it simple and quick for teams to test the performance and usability of their products as well as basic functionality, delivering a better user experience that drives business outcomes.
Is advanced scheduling in Kubernetes achievable?Yes, however, how do you properly accommodate every real-life scenario that a Kubernetes user might encounter? How do you leverage advanced scheduling techniques to shape and describe each scenario in easy-to-use rules and configurations? In his session at @DevOpsSummit at 21st Cloud Expo, Oleg Chunikhin, CTO at Kublr, answered these questions and demonstrated techniques for implementing advanced scheduling. For example, using spot instances and co...
Intel is an American multinational corporation and technology company headquartered in Santa Clara, California, in the Silicon Valley. It is the world's second largest and second highest valued semiconductor chip maker based on revenue after being overtaken by Samsung, and is the inventor of the x86 series of microprocessors, the processors found in most personal computers (PCs). Intel supplies processors for computer system manufacturers such as Apple, Lenovo, HP, and Dell. Intel also manufactu...
Conor Delanbanque has been involved with building & scaling teams in the DevOps space globally. He is the Head of DevOps Practice at MThree Consulting, a global technology consultancy. Conor founded the Future of DevOps Thought Leaders Debate. He regularly supports and sponsors Meetup groups such as DevOpsNYC and DockerNYC.
"There is a huge interest in Kubernetes. People are now starting to use Kubernetes and implement it," stated Sebastian Scheele, co-founder of Loodse, in this SYS-CON.tv interview at DevOps at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
At CloudEXPO Silicon Valley, June 24-26, 2019, Digital Transformation (DX) is a major focus with expanded DevOpsSUMMIT and FinTechEXPO programs within the DXWorldEXPO agenda. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive over the long term. A total of 88% of Fortune 500 companies from a generation ago are now out of business. Only 12% still survive. Similar percentages are found throug...
Today most companies are adopting or evaluating container technology - Docker in particular - to speed up application deployment, drive down cost, ease management and make application delivery more flexible overall. As with most new architectures, this dream takes significant work to become a reality. Even when you do get your application componentized enough and packaged properly, there are still challenges for DevOps teams to making the shift to continuous delivery and achieving that reducti...
Here to help unpack insights into the new era of using containers to gain ease with multi-cloud deployments are our panelists: Matt Baldwin, Founder and CEO at StackPointCloud, based in Seattle; Nic Jackson, Developer Advocate at HashiCorp, based in San Francisco, and Reynold Harbin, Director of Product Marketing at DigitalOcean, based in New York. The discussion is moderated by Dana Gardner, principal analyst at Interarbor Solutions.
Skeuomorphism usually means retaining existing design cues in something new that doesn’t actually need them. However, the concept of skeuomorphism can be thought of as relating more broadly to applying existing patterns to new technologies that, in fact, cry out for new approaches. In his session at DevOps Summit, Gordon Haff, Senior Cloud Strategy Marketing and Evangelism Manager at Red Hat, discussed why containers should be paired with new architectural practices such as microservices rathe...
In 2014, Amazon announced a new form of compute called Lambda. We didn't know it at the time, but this represented a fundamental shift in what we expect from cloud computing. Now, all of the major cloud computing vendors want to take part in this disruptive technology. In his session at 20th Cloud Expo, John Jelinek IV, a web developer at Linux Academy, will discuss why major players like AWS, Microsoft Azure, IBM Bluemix, and Google Cloud Platform are all trying to sidestep VMs and containers...
Using serverless computing has a number of obvious benefits over traditional application infrastructure - you pay only for what you use, scale up or down immediately to match supply with demand, and avoid operating any server infrastructure at all. However, implementing maintainable and scalable applications using serverless computing services like AWS Lambda poses a number of challenges. The absence of long-lived, user-managed servers means that states cannot be maintained by the service. Lo...
With the new Kubernetes offering, ClearDATA solves one of the largest challenges in healthcare IT around time-to-deployment. Using ClearDATA's Automated Safeguards for Kubernetes, healthcare organizations have access to the container orchestration to dynamically deploy new containers on demand, monitor the health of each container for threats and seamlessly roll back faulty application updates to a previous version, avoid system-wide downtime and ensure secure continuous access to patient data.
As Apache Kafka has become increasingly ubiquitous in enterprise environments, it has become the defacto backbone of real-time data infrastructures. But as streaming clusters grow, integrating with various internal and external data sources has become increasingly challenging. Inspection, routing, aggregation, data capture, and management have all become time-consuming, expensive, poorly performing, or all of the above. Elements erases this burden by allowing customers to easily deploy fully man...
Applications with high availability requirements must be deployed to multiple clusters to ensure reliability. Historically, this has been done by pulling nodes from other availability zones into the same cluster. However, if the cluster failed, the application would still become unavailable. Rancher’s support for multi-cluster applications is a significant step forward, solving this problem by allowing users to select the application and the target clusters, providing cluster specific data. Ranc...
StackRox helps enterprises secure their containerized and Kubernetes environments at scale. The StackRox Container Security Platform enables security and DevOps teams to enforce their compliance and security policies across the entire container life cycle, from build to deploy to runtime. StackRox integrates with existing DevOps and security tools, enabling teams to quickly operationalize container and Kubernetes security. StackRox customers span cloud-native startups, Global 2000 enterprises, a...